Matches in Wikidata for { <http://www.wikidata.org/entity/Q62040019> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q62040019 description "clinical trial" @default.
- Q62040019 description "ensayu clínicu" @default.
- Q62040019 description "klinisch onderzoek" @default.
- Q62040019 description "клінічне випробування" @default.
- Q62040019 description "临床试验" @default.
- Q62040019 name "Azacitidine and Rituximab-GDP Immunochemotherapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma" @default.
- Q62040019 type Item @default.
- Q62040019 label "Azacitidine and Rituximab-GDP Immunochemotherapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma" @default.
- Q62040019 prefLabel "Azacitidine and Rituximab-GDP Immunochemotherapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma" @default.
- Q62040019 P1050 Q62040019-C03D10F3-2543-4209-9D49-74C506259A98 @default.
- Q62040019 P1132 Q62040019-AAA44755-E5A9-4667-B86D-E6F7947D2773 @default.
- Q62040019 P1476 Q62040019-0B2B5BC2-91E3-4C8E-BAA9-26E130D9922F @default.
- Q62040019 P1813 Q62040019-317EB074-DE03-4116-B7E0-E9AB05504696 @default.
- Q62040019 P3098 Q62040019-A8F430FF-FA21-4782-974A-B4678B7C315F @default.
- Q62040019 P31 Q62040019-4BB39D4D-408F-4E79-855E-290C75A69F29 @default.
- Q62040019 P4844 Q62040019-2548A479-53F8-4388-88A9-5C428CAD5DF1 @default.
- Q62040019 P4844 Q62040019-DDFEBA55-37D4-4C79-8452-2FD4478FEE2A @default.
- Q62040019 P580 Q62040019-80FEFFCC-BE00-47EC-8DC6-3135E85A2EAB @default.
- Q62040019 P582 Q62040019-E031CCC4-D726-442F-88CC-060EC75CE078 @default.
- Q62040019 P6099 Q62040019-37558546-9F18-4161-BBA9-D08B9032B8D3 @default.
- Q62040019 P6153 Q62040019-65E39EBB-92CE-4D81-B7EC-80E95F743E2A @default.
- Q62040019 P8005 Q62040019-61F4B6CC-109B-4502-B9A1-9CBE05BF02DE @default.
- Q62040019 P8363 Q62040019-80080C81-CC3B-4CC8-9326-E301063B7C0B @default.
- Q62040019 P859 Q62040019-C1FECEA4-9000-4C01-9BD4-1C910E918FD9 @default.
- Q62040019 P1050 Q208414 @default.
- Q62040019 P1132 "+27" @default.
- Q62040019 P1476 "A Phase II Study of Epigenetic Priming Using Azacitidine Followed by Rituximab-GDP Immunochemotherapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma" @default.
- Q62040019 P1813 "EPIC" @default.
- Q62040019 P3098 "NCT03719989" @default.
- Q62040019 P31 Q30612 @default.
- Q62040019 P4844 Q412323 @default.
- Q62040019 P4844 Q416451 @default.
- Q62040019 P580 "2018-12-01T00:00:00Z" @default.
- Q62040019 P582 "2021-11-30T00:00:00Z" @default.
- Q62040019 P6099 Q42824440 @default.
- Q62040019 P6153 Q4403855 @default.
- Q62040019 P8005 Q76649614 @default.
- Q62040019 P8363 Q78089383 @default.
- Q62040019 P859 Q7451679 @default.